Cytel launches Estimed evidence synthesis platform
Cytel Inc. →Cytel launched its Estimed software platform on November 2, 2026 to connect evidence identification, synthesis and quantitative analysis for life sciences teams. The platform combines AI-assisted workflows with analytical methods, including network meta-analysis, while retaining scientific and methodological oversight. Cytel described fragmented work across literature databases, screening tools, spreadsheets, statistical applications and reporting processes as a problem the product addresses. Its intended role is to reduce repetitive work and manual handoffs and help teams reuse evidence in later analysis. Chief Product Officer Kevin Trimm said the aim was to give evidence specialists better tools rather than replace their scientific judgment, linking the launch to Cytel’s existing quantitative expertise.